Population PK modeling of certolizumab pegol in pregnant women with chronic inflammatory diseases

Population PK modeling of certolizumab pegol in pregnant women with chronic inflammatory diseases

Abstract Certolizumab pegol (CZP; CIMZIA™) is the only Fc‐free tumor necrosis factor inhibitor with data from a clinical study demonstrating no to minimal placental transfer. The pharmacokinetics (PK) of certolizumab pegol during pregnancy and postpartum in women with chronic inflammatory diseases w...

Full description

Saved in:
Bibliographic Details
Main Authors: Denis Menshykau (Author), Jagdev Sidhu (Author), Laura Shaughnessy (Author), Rocio Lledo‐Garcia (Author), Pinky Dua (Author), Marie Teil (Author), Akash Khandelwal (Author)
Format: Book
Published: Wiley, 2024-11-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items